Novel Double Target Therapy Combined With Chemotherapy in First-line Treatment of HER2+ Breast Cancer, MA-BC-II-038
Clinical trial NCT05429294 · UNKNOWN
Trial details
- NCT number
- NCT05429294
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2024-05-31
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.